This patent is useful for treatment of neutropenias and other conditions where expansion of bone marrow is required. The patent teaches the use of WSX ligands in stimulation of hematopoiesis. One such ligand is leptin. The patent has 2 independent claims. The first covers enhancing proliferation or differentiation a cell of the hematopoietic lineage through...
This patent covers a cytokine cocktail, that contains midkine, amongst other classical hematopoietic cytokines, useful for the expansion of hematopoietic stem cells. The cocktail may be used for the in vivo treatment of patients that are neutropenic or cytopenic, or may be used for the ex vivo expansion of hematopoietic stem cells.
This patent teaches that the pregnancy associated protien hCG is a stimulator of hematopoiesis. This is an interesting concept since numerous cancers actually secrete hCG. I wonder if during pregnancy, or cancer, there is a high enough gradient of hCG to stimulate hematopoiesis. It is known that pregnant mice have an increase in spleen size, I wonder if the hCG has anything to do with...
This patent covers composition of matter of Jagged 1, as well as its use in stem cell expansion. This patent is useful not only for classical regenerative applications, but also for stimulating production of special immune system cells.
This patent provides various pepties that stimulate proliferation of hematopoietic stem cells. It is not clear from the specification what exactly these peptides are stimulating in order to induce hematopoietic stem cell expansion.
This patent covers various hemaglobin beta chain derived sequences of peptides, as well as their use in combination with opioids for augmentation of hematopoiesis, as well as for antiviral and anticancer activities. The products claimed by the patent appear easy to generate and are potentially useful for other regenerative applications besides stimulation of hematopoiesis.
The connection between the brain and the immune system is well-known, such as the experiments of Pavlovian conditioning of immune responses. Here the inventor covers the use of opiates and certain peptides for stimulation of bone marrow stem cell proliferation. Specific peptide sequences of hematopoietic stem cell stimulators are disclosed including peptide fractions of hemoglobin...
This patent describes peptides derived from hemoglobin that inhibit stem cell proliferation. These peptides are useful for protecting stem cells from killing by chemotherapy or radiation therapy.
This patent teaches how to expand islets as much as 1000 fold !! This is performed through culture of islet stem cells in laminin 5, and other substrates derived from cell lines that are provided in the patent. This patent may be useful to stem cell companies that are currently generating islets from of a variety of stem cell sources.
This patent teaches that laminin-5 is very potent at stimulation of expansion of pancreatic islet cells from stem cells.